Skip to content

Effect of Infant Placement on Iron Stores in Infancy: A Pilot Study

The Effect of Infant Placement at Delivery on Iron Stores in Early Infancy: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00675337
Enrollment
30
Registered
2008-05-09
Start date
2008-06-30
Completion date
2009-04-30
Last updated
2008-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency

Keywords

iron stores, anemia, iron deficiency, infancy, placental transfusion, iron deficiency in infancy, anemia in infancy, placement of neonate

Brief summary

This is a pilot study designed to assess the safety of placing an infant on the mother's abdomen at the time of delivery, prior to clamping the umbilical cord and the effect of placing the infant on the mother's abdomen on the infant's iron stores. It is possible that placing the infant on the mother's abdomen (above the placenta) may lower the infant's iron stores during early infancy.

Interventions

PROCEDUREperineum maintained

infants maintained at the level of the perineum until umbilical cord clamping

PROCEDUREabdominal placement

infants placed on the maternal abdomen prior to umbilical cord clamping

Sponsors

Davison, James, D.O.
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* healthy pregnant women * 37 - 42 weeks of gestation * vaginal delivery * prenatal care initiated prior to 20 weeks of gestation

Exclusion criteria

* maternal diabetes * intrauterine growth restriction * hypertensive disorders of pregnancy * chronic hypertension requiring medical therapy * Apgar score less than 7 at 5 minutes * unusual bleeding prior to delivery * alloimmunization * maternal hemoglobinopathy * need for immediate infant resuscitation preventing adherence to protocol

Design outcomes

Primary

MeasureTime frame
serum ferritin level at 4 months of age4 months

Secondary

MeasureTime frame
blood parameters (hemoglobin and hematocrit)2 months and 4 months
serum ferritin at 2 months2 months
blood parameters (hemoglobin and hematocrit) at 24 hrs of age24 hrs.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026